PH12015500810B1 - Fruit extracts - Google Patents

Fruit extracts

Info

Publication number
PH12015500810B1
PH12015500810B1 PH12015500810A PH12015500810A PH12015500810B1 PH 12015500810 B1 PH12015500810 B1 PH 12015500810B1 PH 12015500810 A PH12015500810 A PH 12015500810A PH 12015500810 A PH12015500810 A PH 12015500810A PH 12015500810 B1 PH12015500810 B1 PH 12015500810B1
Authority
PH
Philippines
Prior art keywords
fruit
platelet aggregation
methods
extracts
medicaments
Prior art date
Application number
PH12015500810A
Other languages
English (en)
Other versions
PH12015500810A1 (en
Inventor
Niamh O'kennedy
Original Assignee
Provexis Natural Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Provexis Natural Products Ltd filed Critical Provexis Natural Products Ltd
Publication of PH12015500810A1 publication Critical patent/PH12015500810A1/en
Publication of PH12015500810B1 publication Critical patent/PH12015500810B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00—Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Plant Pathology (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
PH12015500810A 2008-10-31 2015-04-13 Fruit extracts PH12015500810B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0819959.8A GB0819959D0 (en) 2008-10-31 2008-10-31 Fruit extracts
PCT/GB2009/002593 WO2010049707A2 (en) 2008-10-31 2009-11-02 Fruit extracts

Publications (2)

Publication Number Publication Date
PH12015500810A1 PH12015500810A1 (en) 2017-11-27
PH12015500810B1 true PH12015500810B1 (en) 2022-04-27

Family

ID=40138109

Family Applications (2)

Application Number Title Priority Date Filing Date
PH12015500810A PH12015500810B1 (en) 2008-10-31 2015-04-13 Fruit extracts
PH12020500521A PH12020500521A1 (en) 2008-10-31 2020-03-13 Fruit extracts

Family Applications After (1)

Application Number Title Priority Date Filing Date
PH12020500521A PH12020500521A1 (en) 2008-10-31 2020-03-13 Fruit extracts

Country Status (19)

Country Link
US (4) US20110206794A1 (enExample)
EP (4) EP4218783B1 (enExample)
JP (4) JP2012506901A (enExample)
KR (5) KR20110093992A (enExample)
CN (1) CN102271697B (enExample)
AU (2) AU2009309496B2 (enExample)
BR (1) BRPI0920446B1 (enExample)
CA (1) CA2742213A1 (enExample)
DK (1) DK2349303T3 (enExample)
ES (2) ES2829974T3 (enExample)
GB (1) GB0819959D0 (enExample)
HU (1) HUE033986T2 (enExample)
IL (1) IL212579B (enExample)
MX (1) MX2011004531A (enExample)
NZ (1) NZ592227A (enExample)
PH (2) PH12015500810B1 (enExample)
PL (3) PL3607960T3 (enExample)
PT (1) PT2349303T (enExample)
WO (1) WO2010049707A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0819958D0 (en) * 2008-10-31 2008-12-10 Provexis Natural Products Ltd Therapeutic compositions
GB0819959D0 (en) 2008-10-31 2008-12-10 Provexis Natural Products Ltd Fruit extracts
US9969707B2 (en) * 2011-12-16 2018-05-15 CENTRE DE RECHERCHE INDUSTRIELLE DU QUéBEC Method for extracting anthocyanin derivatives from a plant source
PL2844083T3 (pl) * 2012-04-23 2018-12-31 University Of Oslo Zastosowanie ekstraktu pomidorowego jako środka przeciwdziałającego nadciśnieniu i proces do sporządzania rozpuszczalnego w wodzie ekstraktu pomidorowego bez cukru
CN102796746B (zh) * 2012-08-07 2014-02-19 山东农业大学 一种调节茄科类黄酮和咖啡酰奎尼酸合成的基因片段及其应用
GB201223365D0 (en) 2012-12-24 2013-02-06 Provexis Natural Products Ltd Compositions
EP2948005B1 (en) * 2013-01-22 2020-07-15 Lycored Ltd. Compositions comprising heat-treated clear tomato concentrate
CN103293252B (zh) * 2013-05-09 2015-02-04 杭州师范大学 一种中药的膜富集方法
US9241677B2 (en) 2013-07-02 2016-01-26 MobHealth Corporation Device and methods for assessing, diagnosing, and/or monitoring heart health
EP3050893B1 (en) 2013-09-24 2020-02-26 Ajinomoto Co., Inc. Glycoamino acid and use thereof
JP6392043B2 (ja) * 2014-09-11 2018-09-19 キッコーマン株式会社 トマト含有飲食品の呈味改善方法
EP4445750A3 (en) 2016-11-02 2024-12-25 Provexis Natural Products Limited Water soluble tomato extract protects against adverse effects of air pollution
CN107843665A (zh) * 2017-11-01 2018-03-27 汤臣倍健股份有限公司 一种腺苷含量的测定方法及其应用
CN111529711A (zh) * 2020-05-06 2020-08-14 湖南科诺康美生命科技有限公司 一种抗血小板聚集的芦荟提取物及其在prp制备中的应用
GB202208323D0 (en) 2022-06-07 2022-07-20 Provexis Natural Products Ltd Compostions
CN115645337B (zh) * 2022-12-23 2023-06-02 汤臣倍健股份有限公司 植物提取物组合物及其应用
CN116803404B (zh) * 2023-08-24 2023-12-15 汤臣倍健股份有限公司 水溶性番茄浓缩物在制备减少脱发、育发的产品中的应用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6467173A (en) * 1987-09-04 1989-03-13 Sanei Kagaku Kogyo Kk Preparation of vegetable or fruit juices
JP2722670B2 (ja) 1989-05-30 1998-03-04 ライオン株式会社 高血圧症予防用飲食品及びその製造方法
US5502038A (en) * 1993-06-21 1996-03-26 Medical Research Foundation Of Oregon Cholesterol sequestrant glycosides that inhibit intestinal cholesterol absorption
DE19720767A1 (de) 1997-05-07 1998-11-12 Protekum Umweltinstitut Gmbh O Pharmazeutisches Produkt, insbesondere zur Therapie und Prophylaxe von Herz-Kreislauf-Erkrankungen
GB9808796D0 (en) * 1998-04-24 1998-06-24 Rowett Research Services Limit Antithrombotic agents
ES2197573T3 (es) * 1998-09-02 2004-01-01 Unilever N.V. Productos de tomate enriquecidos en beta-ciclocitral.
AU5965399A (en) 1998-10-12 2000-05-01 Andreas Bockelmann Pharmaceutically active composition
CN1352941A (zh) 2000-11-11 2002-06-12 吉建军 亚油酸胶囊
CA2446274A1 (en) * 2001-05-04 2002-11-14 Ato B.V. Novel regulatory protein
DE10300049A1 (de) 2003-01-03 2004-07-15 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen, die Faktor VIIa inhibieren
ITMI20020632A1 (it) * 2002-03-27 2003-09-29 Indena Spa Processo per la preparazione di estratti di pomodoro ad elevato contenuto di licopene
AU2003261903A1 (en) 2002-11-06 2004-06-07 Kao Corporation Blood fluidity improving agent
EP1633379A4 (en) * 2003-03-27 2009-09-02 Unigen Inc COMPOSITION OF BAMBOO EXTRACT AND CORROSIVE COMPOUNDS WITH TREATMENT AND PREVENTIVE EFFECT FOR INFLAMMATORY DISEASES AND BLEACHING DISEASES
JP4571783B2 (ja) 2003-04-14 2010-10-27 林原 健 抗微生物剤
US20040223962A1 (en) * 2003-05-07 2004-11-11 Riordan Neil H. Method and composition for preventing or reducing edema, deep vein thrombosis and/or pulmonary embolism
EP1481669A1 (en) 2003-05-30 2004-12-01 Yamanouchi Pharmaceutical Co. Ltd. Use of polyhydroxy phenols and polyphenols for modulating p-selectin activity
EP1508325B1 (fr) * 2003-08-21 2009-03-11 Nestec S.A. Concentré naturel de Lycopène et procédé d'obtention
CN1234387C (zh) * 2004-01-12 2006-01-04 李迺灿 一种具有清肺功能的组合物及其制备方法
FR2871378B1 (fr) 2004-06-15 2007-03-30 Seppic Sa Nouveau medicament a base de flavanois et de leurs derives et son utilisation pour obtenir un medicament destine a la prevention de la restenose et de la maladie atheromateuse chez les patients coronariens
EP1640001A1 (en) 2004-09-24 2006-03-29 New Pharma Investments Holding Composition against cardiovascular diseases
CN100488535C (zh) 2004-12-09 2009-05-20 郭富凤 一种番茄红素混合物
US7419960B2 (en) * 2005-01-07 2008-09-02 Hong Kong Baptist University Hemiterpene glycosides with anti-platelet aggregation activities from Ilex pubescens
GB0502985D0 (en) * 2005-02-14 2005-03-16 Provexis Ltd Therapeutic uses of tomato extracts
WO2006094120A2 (en) 2005-03-02 2006-09-08 The Regents Of The University Of California Treatment for embolic stroke
JP4260158B2 (ja) * 2005-07-07 2009-04-30 長谷川香料株式会社 トマトジュース濃縮物の製造方法およびトマト風味組成物
AT503521A1 (de) 2006-05-05 2007-11-15 Omnica Gmbh Verwendung eines extraktes von kiwi-frucht
GB0610790D0 (en) * 2006-06-02 2006-07-12 Provexis Natural Products Ltd Therapeutic uses of tomato extracts
US20080009449A1 (en) * 2006-07-07 2008-01-10 Kailash Prasad Lignan complex derived from flax seed used for treatment of hypercholesterolemic atherosclerosis
SG191445A1 (en) 2006-12-22 2013-07-31 Univ Johns Hopkins Anti-cholesterolemic compounds and methods of use
US8759327B2 (en) 2007-04-16 2014-06-24 The Regents Of The University Of Michigan Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism
GB0819959D0 (en) 2008-10-31 2008-12-10 Provexis Natural Products Ltd Fruit extracts
GB0819958D0 (en) 2008-10-31 2008-12-10 Provexis Natural Products Ltd Therapeutic compositions
PL2844083T3 (pl) * 2012-04-23 2018-12-31 University Of Oslo Zastosowanie ekstraktu pomidorowego jako środka przeciwdziałającego nadciśnieniu i proces do sporządzania rozpuszczalnego w wodzie ekstraktu pomidorowego bez cukru
GB201223365D0 (en) * 2012-12-24 2013-02-06 Provexis Natural Products Ltd Compositions

Also Published As

Publication number Publication date
ES2829974T3 (es) 2021-06-02
CN102271697A (zh) 2011-12-07
EP3173088A3 (en) 2017-08-23
KR20190117800A (ko) 2019-10-16
PH12015500810A1 (en) 2017-11-27
JP2018030888A (ja) 2018-03-01
US20180256666A1 (en) 2018-09-13
BRPI0920446B1 (pt) 2024-03-05
JP2012506901A (ja) 2012-03-22
WO2010049707A3 (en) 2011-09-29
IL212579B (en) 2021-05-31
DK2349303T3 (en) 2017-04-24
PT2349303T (pt) 2017-04-11
MX2011004531A (es) 2011-05-30
EP3173088A2 (en) 2017-05-31
HUE033986T2 (en) 2018-01-29
EP3607960B1 (en) 2023-04-12
GB0819959D0 (en) 2008-12-10
EP4218783B1 (en) 2025-07-30
WO2010049707A2 (en) 2010-05-06
EP2349303A2 (en) 2011-08-03
KR20180049265A (ko) 2018-05-10
KR20210054006A (ko) 2021-05-12
PH12020500521A1 (en) 2021-10-04
KR102403082B1 (ko) 2022-05-30
EP2349303B1 (en) 2017-01-11
AU2009309496A1 (en) 2010-05-06
PL2349303T3 (pl) 2017-07-31
JP2019172692A (ja) 2019-10-10
EP3607960A1 (en) 2020-02-12
KR20170010100A (ko) 2017-01-25
EP4218783A1 (en) 2023-08-02
KR102246163B1 (ko) 2021-04-29
KR102032262B1 (ko) 2019-10-16
CA2742213A1 (en) 2010-05-06
US20210330732A1 (en) 2021-10-28
BRPI0920446A2 (pt) 2015-12-22
WO2010049707A9 (en) 2011-11-03
AU2016202312A1 (en) 2016-05-05
EP3173088B1 (en) 2020-09-23
JP2015057440A (ja) 2015-03-26
PL3173088T3 (pl) 2021-01-25
PL3607960T3 (pl) 2023-08-21
NZ592227A (en) 2013-02-22
IL212579A0 (en) 2011-07-31
US10973865B2 (en) 2021-04-13
US20110206794A1 (en) 2011-08-25
JP7049291B2 (ja) 2022-04-06
JP6545237B2 (ja) 2019-07-17
AU2016202312B2 (en) 2017-11-02
AU2009309496B2 (en) 2016-01-21
KR20110093992A (ko) 2011-08-19
US20140147537A1 (en) 2014-05-29
ES2621793T3 (es) 2017-07-05
CN102271697B (zh) 2014-04-09

Similar Documents

Publication Publication Date Title
PH12020500521A1 (en) Fruit extracts
RU2523384C2 (ru) Фитокомплекс из плодов бергамота, способ производства и применение в качестве пищевой добавки и в области фармакологии
WO2011027301A1 (en) Algae spirulina platensis preservation by natural honey
Fernández et al. Effect of boldo (Peumus boldus Molina) infusion on lipoperoxidation induced by cisplatin in mice liver
TW201713330A (zh) 肌肉脂肪化抑制用組成物
CN102715614A (zh) 一种含有黑大蒜的新饮料
KR101661402B1 (ko) 아스파라거스, 울금추출물, 미배아대두발효추출물을 포함하는 숙취해소용 조성물
CN104232391A (zh) 一种降压降脂葡萄酒及其制备方法
CN105999247A (zh) 一种水蛭素和生水蛭药酒及制备方法与应用
CN104207277B (zh) 一种即饮橄榄油补充剂
JP5688233B2 (ja) Ｔａｒｃ産生抑制剤
Chakraborty et al. Effect of caffeine, norfloxacin and nimesulide on heartbeat and VEGF expression of zebrafish larvae
WO2008129802A1 (ja) 血清尿酸値低下剤および血清尿酸値を低下させる旨の表示を付した飲食品
CN105331501B (zh) 一种人参酒及其制备方法和应用
Abdelazim et al. Oyster mushroom (Pleurotus ostreatus) strain 238 ameliorates the oxidative stress in STZ-induced diabetic mice
CN1309393C (zh) 一种辅助降血脂的磷脂颗粒剂
JP2006342073A (ja) 免疫活性増強成分、並びにそれを含む飲食物類及び医薬部外品類
JP6159198B2 (ja) Ｐｄｅ３阻害剤
TW201036629A (en) Composition and method for improving skin elasticity
JP2016108301A (ja) 骨芽細胞分化促進剤
Ziedan et al. Effects of broccoli on the nutritional status of diabetic rates
JP5651834B2 (ja) 赤血球凝集阻害剤、および赤血球の凝集阻害方法
JP6476430B2 (ja) ウロキナーゼ阻害剤及び血管新生阻害剤
US10478462B2 (en) Alcohol metabolism promoter
CN103830178A (zh) 一种蒜氨酸微乳及其制备方法和应用